Estimated Societal Value of Lecanemab in Patients with Early Alzheimer’s Disease Using Simulation Modeling

INTRODUCTION: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with memory, cognitive, and behavioral deficits, and brings significant economic burden on caregivers and healthcare systems. This study aims to estimate the long-term societal value of lecanemab plus stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahami Monfared, Amir Abbas, Ye, Weicheng, Sardesai, Aditya, Folse, Henri, Chavan, Ameya, Kang, Kang, Zhang, Quanwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195963/
https://www.ncbi.nlm.nih.gov/pubmed/36929345
http://dx.doi.org/10.1007/s40120-023-00460-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195963/
https://www.ncbi.nlm.nih.gov/pubmed/36929345
http://dx.doi.org/10.1007/s40120-023-00460-1

Ejemplares similares